Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

Circulation

Volumn 105, Issue 16, 2002, Pages 1890-1896

  Verma, Subodh ^a   Li, Shu Hong ^a   Badiwala, Mitesh V ^a   Weisel, Richard D ^a   Fedak, Paul W M ^a   Li, Ren Ke ^a   Dhillon, Bikramjit ^a   Mickle, Donald A G ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Cell adhesion molecules; Endothelin; Endothelium; Protein, C reactive

Indexed keywords

BOSENTAN; C REACTIVE PROTEIN; CD14 ANTIGEN; CD32 ANTIGEN; CYTOKINE; ENDOTHELIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; SAPHENOUS VEIN;

ANTIBODIES; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CELL ADHESION MOLECULES; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOPROTEINS, LDL; MACROPHAGES; MODELS, CARDIOVASCULAR; SULFONAMIDES;

EID: 0037161360     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000015126.83143.B4     Document Type: Article

References (33)

1. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
2. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
3. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease
4. High sensitivity C-reactive protein for predicting cardiovascular disease: An inflammatory hypothesis
5. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening
6. The role of C-reactive protein in cardiovascular disease risk
7. Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation
8. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
9. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
10. C-reactive protein, inflammation, and coronary risk
11. Novel risk factors and markers for coronary disease
12. Clinical efficacy of an automated high-sensitivity C-reactive protein assay
13. Novel clinical markers of vascular wall inflammation
14. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs
15. Direct proinflammatory effect of C-reactive protein on human endothelial cells
16. C-reactive protein-mediated low-density lipoprotein uptake by macrophages: Implications for atherosclerosis
17. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes
18. Atherosclerosis: The road ahead
19. Atherosclerosis: An inflammatory disease
20. Atherosclerosis: Cell biology and lipoproteins
21. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure?
22. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention
23. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein
24. C-reactive protein: A physiological activator of interleukin 6 receptor shedding
25. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
26. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
27. C-reactive protein: Linking inflammation to cardiovascular complications
28. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: Relationship with age, sex, and hormone replacement treatment
29. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-κB in human vascular smooth muscle cells
30. Pathophysiology of endothelin in the cardiovascular system
31. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
32. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor α
33. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment